Sudeep Pharma
add_icon

Sudeep Pharma

847.65
+10.20
(1.22%)
Market Cap
9,574.09 Cr
PE Ratio
54.24
Volume
1,72,199.00
Day High - Low
875.00 - 837.45
52W High-Low
894.45 - 524.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
9,574.09 Cr
EPS
15.50
PE Ratio
54.24
PB Ratio
10.70
Book Value
78.21
EBITDA
250.50
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
19.41
Debt to Equity
0.25
Analyst Rating and Forecast
- By Refinitiv from2 analysts
SELL
Analysts have suggested that investors can sell this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+50.00 %
+50.00 %
Sell
Sell+50.00 %
+50.00 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Sudeep Pharma Limited has published the notice for its 37th Annual General Meeting and e-voting details in newspapers on July 11, 2026.
positive
Sudeep Pharma Limited has announced a dividend of ₹1.50 per share for FY 2025-26 and scheduled its 37th AGM for August 4, 2026.
neutral
Sudeep Pharma Ltd appointed Milin Mehta as Non-Executive Non-Independent Director on June 26, 2026. The appointment is subject to shareholder approval.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,951.50
#1 4,68,230.22
40.45
#1 61,673.90
12.69
#1 11,565
25.80
69.50
7,273.00
1,93,075.30
74.28
10,560.00
8.73
2,520
13.44
73.34
5,017.80
1,69,825.15
78.68
13,886.20
20.34
2,138
-26.91
80.61
1,156.90
1,16,411.21
22.08
27,657.90
17.64
5,026
7.82
64.38
1,438.00
1,16,168.16
30.10
29,044.60
2.24
3,870
-55.32
55.25
2,493.00
1,13,988.07
#1 21.08
27,487.50
19.98
5,345
#1 87.72
65.40
2,543.10
1,05,029.01
53.92
14,277.60
12.03
1,750
31.75
59.45
1,229.50
1,02,622.56
25.01
35,058.60
3.90
4,158
-86.05
34.68
1,550.20
89,195.08
25.75
33,384.70
3.21
3,376
1.99
54.09
1,554.30
83,909.91
94.65
6,867.80
#1 22.01
890
21.18
65.68
Growth Rate
Revenue Growth
31.19 %
Net Income Growth
25.67 %
Cash Flow Change
-25.82 %
ROE
-31.00 %
ROCE
-30.38 %
EBITDA Margin (Avg.)
-4.18 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
81
151
118
161
130
173
179
189
Expenses
52
85
76
99
81
107
112
120
EBITDA
30
65
42
63
49
66
67
69
Operating Profit %
35 %
43 %
34 %
37 %
35 %
34 %
35 %
34 %
Depreciation
3
3
3
3
3
4
4
4
Interest
2
1
1
2
2
2
1
2
Profit Before Tax
26
62
38
58
44
60
62
63
Tax
9
13
9
14
13
13
14
14
Net Profit
17
49
29
44
31
47
48
49
EPS in ₹
4.49
4.49
2.65
4.07
2.84
4.20
4.29
4.38

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
131
213
344
420
514
717
1,175
Fixed Assets
60
68
137
158
180
189
337
Current Assets
56
100
197
230
275
424
624
Capital Work in Progress
8
24
8
26
45
88
185
Investments
0
0
0
3
0
0
0
Other Assets
63
121
199
233
289
440
653
Total Equity & Liabilities
131
213
344
420
514
717
1,175
Current Liabilities
37
80
147
171
137
175
202
Non Current Liabilities
13
19
34
26
21
49
75
Total Equity
81
114
163
223
356
493
898
Reserve & Surplus
80
113
162
222
355
481
872
Share Capital
1
1
1
1
1
12
11

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
8
10
-11
4
23
Investing Activities
-23
-40
-38
-50
-49
-79
Operating Activities
10
35
-3
48
66
49
Financing Activities
12
13
51
-10
-13
53

Share Holding

% Holding
Jun 2025
Nov 2025
Dec 2025
Mar 2026
Promoter
91.07 %
89.36 %
76.15 %
76.15 %
FIIs
0.00 %
0.00 %
1.67 %
1.55 %
DIIs
0.00 %
0.00 %
17.60 %
18.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
3.27 %
3.11 %
Others
8.93 %
10.64 %
1.31 %
1.07 %
No of Share Holders
16
26
43,599
36,503

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
04 Aug 2026 802.30 837.00
23 Jul 2026 DIVIDEND Dividend
₹ 1.50 /share
23 Jul 2026 650.10 837.00
19 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Dec 2025 698.20 672.95
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 593.90 618.30
21 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2026 634.70 650.10

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Intimation Of Record Date For Payment Of Final Dividend On Equity Shares For The Financial Year 2025-265 days ago
Letter To Shareholders In Relation To Integrated Annual Report Of The Company For The Financial Year 2025-265 days ago
Reg. 34 (1) Annual Report.5 days ago
Notice Of 37Th Annual General Meeting5 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
Announcement under Regulation 30 (LODR)-Change in ManagementJun 26, 2026
Board Meeting Outcome for Appointment Of Mr. Milin Mehta As An Additional Director (Non-Executive & Non-Independent)Jun 26, 2026
Closure of Trading WindowJun 25, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 28, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 21, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 21, 2026
Submission Of Financial Results For The Year Ended 31St March 2026May 21, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026May 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2026
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financials For The Fourth Quarter And Year Ended 31St March 2026.May 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Closure of Trading WindowMar 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Un-Audited Financial Results As On 31.12.2025Feb 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 06.02.2026Feb 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business ItemsFeb 02, 2026
Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company.Jan 22, 2026
General UpdateJan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 22, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationDec 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 20, 2025
Submission Of Financials As On Quarter And Half Year Ended 30Th September 2025Dec 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 19Th December 2025Dec 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 And Other Business ItemsDec 15, 2025
Intimation Of Unsecured Loan Granted To Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The CompanyDec 09, 2025
Closure of Trading WindowNov 28, 2025
Listing of Equity Shares of Sudeep Pharma LtdNov 28, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.01%
75
0.01%
0.01%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Quant Small Cap Fund Direct Plan-Growth
0.04%
0
0.00%
0.00%
Axis Multi Asset Allocation Direct Plan-Growth
0.16%
0
0.00%
0.01%
Axis Small Cap Fund Direct-Growth
0.58%
0
0.00%
0.04%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Equity Savings Fund Direct-Growth
0.40%
0
0.00%
0.03%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.72%
0
0.00%
0.09%
Groww Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
HDFC Innovation Fund Direct-Growth
0.36%
0
0.03%
0.04%
HDFC Manufacturing Fund Direct-Growth
0.71%
0
0.00%
0.08%
ICICI Prudential MNC Fund Direct-Growth
0.00%
0
0.00%
-1.09%
Mirae Asset Healthcare Fund Direct-Growth
0.00%
0
0.00%
-0.37%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.45%
0
0.00%
-0.03%
Axis Equity Savings Fund Direct-Growth
0.38%
0
0.00%
0.04%
Angel One Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.00%
UTI Healthcare Fund Direct-Growth
1.72%
0
0.00%
0.00%
Nippon India Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
PGIM India ELSS Tax Saver Fund Direct-Growth
0.63%
0
0.00%
0.06%
PGIM India Small Cap Fund Direct-Growth
1.23%
0
0.00%
0.09%
Motilal Oswal Large Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
SBI Healthcare Opportunities Fund Direct Plan-Growth
2.31%
0
0.00%
0.10%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth
0.24%
0
0.00%
0.04%
WhiteOak Capital Balanced Advantage Fund Direct-Growth
0.11%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
56.96
ATR(14)
Less Volatile
38.07
STOCH(9,6)
Neutral
30.27
STOCH RSI(14)
Neutral
37.77
MACD(12,26)
Bearish
-5.55
ADX(14)
Strong Trend
36.95
UO(9)
Bearish
38.54
ROC(12)
Uptrend And Accelerating
3.49
WillR(14)
Neutral
-53.72